The accumulation of advanced glycation end products is implicated in the development and progression of diabetic kidney disease. No study has examined whether stimulating advanced glycation clearance via receptor manipulation is reno-protective in diabetes. Podocytes, which are early contributors to diabetic kidney disease and could be a target for reno-protection. To examine the effects of increased podocyte oligosaccharyltransferase-48 on kidney function, glomerular sclerosis, tubulointerstitial fibrosis and proteome (PXD011434), we generated a mouse with increased oligosaccharyltransferase-48kDa subunit abundance in podocytes driven by the podocin promoter. Despite increased urinary clearance of advanced glycation end products, we observed a decline in renal function, significant glomerular damage including glomerulosclerosis, collagen IV deposition, glomerular basement membrane thickening and foot process effacement and tubulointerstitial fibrosis. Analysis of isolated glomeruli identified enrichment in proteins associated with collagen deposition, endoplasmic reticulum stress and oxidative stress. Ultra-resolution microscopy of podocytes revealed denudation of foot processes where there was co-localization of oligosaccharyltransferase-48kDa subunit and advanced glycation end-products. These studies indicate that increased podocyte expression of oligosaccharyltransferase-48kDa subunit results in glomerular endoplasmic reticulum stress and a decline in kidney function.
Introduction
There is a rising global pandemic of diabetes [1, 2] , defined by persistent hyperglycemia, a principal risk factor for the development of concomitant chronic complications [3, 4] . Hence, the numbers of individuals with diabetic kidney disease (DKD), a major complication, are burgeoning. DKD is an important risk factor for both end-stage kidney disease and cardiovascular disease [3, 5] . While renin-angiotensin system blockade including angiotensinconverting-enzyme inhibition is first line therapy for DKD, in general these agents only achieve a ~ 20% reduction in end-stage kidney disease [6] .
Advanced glycation end products (AGEs) are a heterogeneous and complex group of nonenzymatic, post-translational modifications to amino acids and proteins, which include hemoglobin A1C (HbA1C) a clinical marker used for the diagnosis of diabetes. Their endogenous formation can be exacerbated by chronic hyperglycemia and oxidative stress [7] and therefore the accumulation of AGEs occurs at an accelerated rate in diabetes [8, 9] .
Increases in AGE formation on skin collagen [10] [11] [12] and within the circulation [13, 14] predict poor prognosis for patients with diabetes including increased risk for kidney and cardiovascular disease. The kidneys are a major site of AGE detoxification through the filtration of circulating AGEs and their subsequent active uptake and excretion [15, 16] . Therefore, AGE accumulation is seen in diabetic patients with chronic kidney disease [17, 18] . Therapies which lower AGE accumulation have shown benefit in Phase II clinical trials for the treatment DKD in individuals with Type 2 diabetes [19] .
OST48, an evolutionarily conserved type 1 transmembrane protein [20] , is encoded by the DDOST (Dolichyl-diphosphooligosaccharide-protein glycosyltransferase 48 kDa subunit) gene and has been postulated to function as a receptor for AGE turnover and clearance [21, 22] .
OST48 is expressed in most cells and tissues [23] , including macrophages [24] and mononuclear cells [25] . In the kidney, previous studies have shown OST48 expression in glomerular cells including podocytes [23, 26] and mesangial cells [24] where in the podocytes it is postulated to mediate the uptake and secretion of AGEs [27] . The process whereby AGEs are cleared by OST48 in the kidney is not well understood [28] , but is thought to involve degradation of AGEs and then excretion via the urine [29] . A strong link exists between impaired podocyte function and albuminuria, increased urinary AGE excretion and glomerulosclerosis [30] [31] [32] [33] [34] [35] .
Early damage to the glomeruli, specifically podocyte structural damage, is characteristic of DKD [36] [37] [38] . AGEs can induce podocyte cell-cycle arrest [39] , hypertrophy [39] and apoptosis [40] , while a systemic reduction in AGEs has been shown to improve podocyte and kidney function [41] . Hence, increased facilitation of AGE excretion by increasing OST48 expression could potentially improve podocyte health and alleviate DKD. Currently there are no reported studies identifying whether podocyte OST48 facilitates urinary AGE excretion and subsequently if targeting podocyte OST48 could influence kidney health.
Here, we examined if facilitating greater AGE clearance via modestly increasing podocytespecific OST48 expression could attenuate the development and progression of DKD.
Results
Generation of a podocyte-specific OST48 knock-in mouse model. Mice were generated with a podocyte specific knock-in of human OST48 (DDOST+/-Pod-Cre ) driven by the podocin promoter ( Supplementary Information 1A-B ) inserted at the ROSA26 locus and showed no differences in any anthropometric parameters or long-term glycemic control ( Table 1) . We have previously confirmed that this genetic modification does not affect N-glycosylation machinery [42] . Mice with experimentally induced diabetes were characterized by elevated fasting blood glucose and glycated hemoglobin (GHb) ( Table 1) . Irrespective of genotype, diabetic mice exhibited a lower body weight, renal hypertrophy, increased consumption of food and water and a greater urinary output when compared with non-diabetic mice ( Table 1) . Interestingly, it appeared that there was also a significant interactive effect of diabetes on the abundancy of OST48 in glomeruli (Figure 1B; left) . Localized increases in OST48 abundance in WT-1 positive cells were demonstrated in DDOST+/-Pod-Cre mice by confocal microscopy ( Figure 1C) . A podocyte-specific increase in OST48 expression was confirmed using ultraresolution 3-dimensional structured illumination microscopy (3D-SIM) ( Figure 1D) . This included increased localization of OST48 to damaged podocyte foot processes, as indicated by nephrin loss (Figure 1D) , which was particularly evident in 3D reconstruction videos ( Supplementary Figure 2A and Supplementary Video 1). This localization of OST48 to areas of damaged foot processes was unexpected, since the prevailing model is that increasing OST48 abundance could improve declining kidney function by sequestering AGEs [43] . These initial findings of damage to podocyte foot processes warranted further investigation of kidney function in DDOST+/-Pod-Cre mice, and whether increasing podocyte expression of OST48 affected glomerular filtration. Diabetes increased serum creatinine in wild type mice ( Figure 2C ) and decreased creatinine clearance ( Figure 2D) , which tended to further decrease in DDOST+/-Pod-Cre mice, although this did not reach statistical significance ( Figure 2D ). Compared to wild-type mice, DDOST+/-Pod-Cre mice averaged a 72% reduction in creatinine clearance following simultaneous blood and 24-hour urine collection (Figure 2E ; P = 0.0052) in agreement with FITC-sinistrin based GFR assessment (Figure 2A) . Diabetes increased 24-hour urinary albumin excretion rate, but this did not differ between wild-type and DDOST+/-Pod-Cre mice (Figure 2F and 2G) . Figure 3B ) than wild-type mice which was not further elevated by diabetes. Glomerular collagen IV accumulation was also present in all diabetic mice ( Figure 3B) . By electron microscopy, glomerular basement membrane thickening and podocyte foot process effacement were seen in DDOST+/-Pod-Cre , but not in wild-type mice (Figure 3C) . In glomerular fractions from mouse kidney cortices, SWATH-MS proteomics identified significant increases in the abundance of collagen proteins ( Figure   3D ). Specifically, both diabetes and increased podocyte OST48 expression caused an increased abundance of collagen 1, collagen 6 and other structural collagen proteins ( Figure 3D) . Given that all DDOST+/-Pod-Cre mice exhibited a decline in kidney function, we suspected that in addition to damaged glomeruli there would be other structural evidence of progressive kidney damage in the tubules of these mice. As expected, diabetes increased tubulointerstitial fibrosis in WT mice (Figure 4A-C) . In addition, there was significant tubulointerstitial fibrosis in all Podocyte OST48-mediated AGE accumulation resulted in ER stress. ER stress at sites of AGE accumulation within damaged podocytes was examined. DDOST+/-Pod-Cre mice exhibited an increase in the ER stress markers GRP-78 and spliced XBP-1 when compared to wild-type mice (Figure 6A ). Furthermore, these ER stress markers were further increased by diabetes ( Figure 6A) . This was confirmed using SWATH-MS proteomics of glomerular enriched fractions, where diabetic DDOST+/-Pod-Cre mice showed significantly higher abundance of proteins associated with ER stress (GRP75 and GRP78) compared to non-diabetic wild-type mice (Figure 6B) . Antioxidant enzymes SOD1/SODC and SOD2/SODM were also increased by diabetes in wild-type mice (Figure 6B) . Compared with non-diabetic mice, glomerular fractions from diabetic wild-type and DDOST+/-Pod-Cre mice had significantly higher levels of proteins associated with mitochondrial ATP synthesis, particularly biosynthesis of complex I components (NADH dehydrogenase:ubiquinone) ( Figure 6C ).
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Increases in podocyte OST48 expression decreases GFR
Discussion
Lowering AGE burden, including by facilitating renal AGE clearance, has been suggested as a possible treatment for DKD. However, the assertion that increasing renal AGE clearance receptors such as OST48 may protect against DKD has not been previously investigated. Here, we have shown for the first time that increasing OST48 in a podocyte-specific manner decreased glomerular filtration and caused podocyte structural damage including foot process effacement, leading to glomerulosclerosis and tubulointerstitial fibrosis, which were further exacerbated by diabetes. Surprisingly, in non-diabetic mice the decline in GFR and increased podocyte and glomerular damage were seen in the absence of elevations in albuminuria.
Mechanistically, increases in OST48 in podocytes were marked by increased podocyte specific AGE uptake resulting in oxidative and endoplasmic reticulum stress, which is independent of changes to the N-glycosylation machinery and subsequent kidney functional and structural decline (Figure 7) , where previously it has been shown that AGE uptake into cultured podocytes induces hypertrophy [39] and apoptosis [40] .
It was particularly interesting that albuminuria was not seen concomitantly with the loss of GFR in non-diabetic DDOST+/-Pod-Cre mice despite podocyte foot effacement, thickening of the glomerular basement membrane and glomerulosclerosis. Although surprising, this is consistent with clinical observations. For example, the prospective longitudinal Joslin Proteinuria Cohort studies [44, 45] identified that the overall prevalence of normo-albuminuria in patients with progressive kidney disease was around 10% and that regression from microand macro-albuminuria to normo-albuminuria was repeatedly observed. We observed podocyte foot effacement and glomerular basement membrane thickening, which are commonly attributed as causes of micro-and macro-albuminuria. This finding is consistent with other postulated models of the origins of albuminuria, such as the high glomerular sieving coefficient (GSC) hypothesis [46, 47] . This hypothesis suggests that albuminuria is driven by proximal tubule damage which prevents the reabsorption/processing of albumin by these cells. In support of this model, tubulointerstitial fibrosis was more pronounced in diabetic mice regardless of their genotype, and they also had concomitant increases in urinary albumin excretion which not seen in non-diabetic mice. Alternatively, the absence of macro-albuminuria seen in mice with increased podocyte expression of OST48 could be attributed to the significant decline in GFR, as this would limit the flux of albumin into the urine.
Although we showed that increases in podocyte OST48 expression decreased renal AGE accumulation and increased urinary AGE excretion, this was not associated with renoprotection. In fact, this resulted in significant renal disease. We have shown for the first time that OST48 and AGEs colocalize within podocytes in areas of foot process denudation and damage. We observed that OST48 facilitation of podocyte AGE accumulation resulted in a cascade of ER stress culminating in podocyte foot process effacement, GBM expansion, and renal functional decline. Increasing the urinary flux of AGEs has however been previously shown to impair renal function in both healthy humans [41, 48] and early in the development of diabetic kidney disease in rodent models [35, 49] .
Taken together, these results suggest that specifically increasing podocyte exposure and uptake of AGEs by facilitating their flux into the urine is sufficient to induce significant kidney damage.
Translational Statement
Advanced glycation end-products (AGEs) have long been considered an important pathological factor contributing to diabetic kidney disease (DKD). However, targeting AGEs has proven difficult due to the lack of knowledge in the signaling pathways surrounding its lesser known receptors such as OST48, and how these impact kidney function in health and disease. This paper describes the role of OST48 in the podocytes using genetic manipulation of animal models, proteomics and 3D-SIM microscopy. It demonstrates that facilitation of Figure 1A) by Ozgene Australia (Ozgene, Perth, WA, Australia). Between 6-8 weeks of age (Week 0), experimental diabetes (DIAB) was induced in male wild-type (n = 9) and DDOST+/-Pod-Cre (n = 10) mice by low dose intraperitoneal injection of streptozotocin [50] . Non-diabetic male wildtype (n = 11) and DDOST+/-Pod-Cre (n = 7) mice received equivalent injections of sodium citrate buffer alone. After 10 days of recovery, blood glucose concentrations were determined and then repeated weekly to ensure mice had diabetes ([blood glucose]>15mmol/L). Mice were allowed access to food and water ad libitum and were maintained on a 12-hour light:dark cycle at 22°C. All mice received a diet of standard mouse chow (AIN-93G) (Specialty Feeds, Glen Forrest, Perth, Australia). At 0 and 12 weeks of the study, mice were housed in metabolic cages (Iffa Credo, France) for 24 hours to determine food and water consumption and collect urine.
Urine output was also measured during caging and urinary glucose determined by a glucometer (SensoCard Plus, POCD, Australia).
Glomerular and tubule enrichment. Kidneys were decapsulated and the medulla discarded.
Cortex was kept cold, minced, and passed gently through three stacks of fine-mesh sieves (250µm, 70µm and 45µm). Tubular-enriched proteins were contained in the elute whilst the glomerular-enriched proteins were located on the top of the 70µm sieve. Enriched proteins were collected and processed for mass spectrometry analysis. Glomerular-(SYNPO, ACTN4) and tubular-specific (AQP1, DIC, S22A6) proteins were significantly enriched in respective fractions (Supplementary Figure 1C) .
Biochemical analyses. Nε-(Carboxymethyl)lysine (CML) concentrations in plasma and urine
were measured by an in-house indirect ELISA as previously described [28] . Urinary albumin (Bethyl Laboratories, United States) was normalized to the 24-hour flow rate of urine. Serum and urinary creatinine were measured spectrophotometrically at 505nm (Roche/Hitachi 902 Analyzer, Roche Diagnostics GmBH, Germany) using the Jaffe method.
Glomerular Filtration Rate. At 0 and 12 weeks of the study, GFR was estimated in conscious mice using the transcutaneous decay of retro-orbitally injected FITC-sinistrin (10mg/100g body weight dissolved in 0.9% NaCl), as previously described [51] . GFR was calculated from the rate constant (α2) of the single exponential excretion phase of the curve and a semiempirical factor.
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) proteomics.
Fractions enriched for either glomeruli or tubules were processed as previously described [52] . Peptides were desalted and analyzed by Information Dependent Acquisition LC-MS/MS as described [53] using a Prominence nanoLC system (Shimadzu, Australia) and Triple TOF 5600 mass spectrometer with a Nanospray III interface (AB SCIEX, United States). SWATH-MS analysis was performed [54] and differentially abundant proteins were analyzed using DAVID [55] . Processed proteomic data sets are available in the Supplementary Information. Glomerulosclerotic index (GSI). GSI as a measure of glomerular fibrosis was evaluated in a blinded manner by a semi-quantitative method [57] . Severity of glomerular damage was assessed on the following parameters; mesangial matrix expansion and/or hyalinosis of focal adhesions, true glomerular tuft occlusion, sclerosis and capillary dilation.
Fixation, tissue processing and acquisition of data from electron microscopy. Renal cortex was processed as previously described [58] . Sections were cut at 60nm on a Leica UC6 ultramicrotome (Leica, Germany) and were imaged at 80kV on a Jeol JSM 1011 transmission electron microscope (Jeol, United States) equipped with an Olympus Morada (Olympus, Japan) digital camera. Quantification of foot process width and GBM expansion was assessed as previously described [59] .
Statistics.
Results are expressed as mean ± SD (standard deviation) and assessed in GraphPad Results are expressed as mean ± SD with either two-way ANOVA or paired t-test analysis (n = 3-8) *P < 0.05, **P < 0.01, ***P < 0.001. 
